Pholcodine-containing medicinal products are no longer available on the UK market
Following a review by the Medicines and Healthcare products Regulatory Agency (MHRA), the UK regulator has taken the precautionary step to recall medicines containing pholcodine.
The DHPC (direct to healthcare professional communication) letter below has been sent to healthcare providers from PAGB on behalf of the Marketing Authorisation Holders of medicines containing pholcodine. All batches of the products listed in the Appendix I of the letter have been recalled.
Read the letter. If you have any queries about the products being recalled, please contact the relevant company via the details in the table.
